BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 20124483)

  • 1. miR-146a suppresses invasion of pancreatic cancer cells.
    Li Y; Vandenboom TG; Wang Z; Kong D; Ali S; Philip PA; Sarkar FH
    Cancer Res; 2010 Feb; 70(4):1486-95. PubMed ID: 20124483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells.
    Li Y; VandenBoom TG; Wang Z; Kong D; Ali S; Philip PA; Sarkar FH
    Cancer Res; 2010 Apr; 70(8 Suppl):5703. PubMed ID: 25242818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.
    Hamada S; Satoh K; Fujibuchi W; Hirota M; Kanno A; Unno J; Masamune A; Kikuta K; Kume K; Shimosegawa T
    Mol Cancer Res; 2012 Jan; 10(1):3-10. PubMed ID: 22064652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p.
    Zhu D; Zheng S; Fang C; Guo X; Han D; Tang M; Fu H; Jiang M; Xie N; Nie Y; Yao X; Chen Y
    Cancer Lett; 2020 May; 477():107-121. PubMed ID: 32120026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis.
    Liu J; Zhu C; Zhang L; Lu H; Wang Z; Lv J; Fan C
    Hum Cell; 2020 Oct; 33(4):1176-1185. PubMed ID: 32757096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-301a as an NF-κB activator in pancreatic cancer cells.
    Lu Z; Li Y; Takwi A; Li B; Zhang J; Conklin DJ; Young KH; Martin R; Li Y
    EMBO J; 2011 Jan; 30(1):57-67. PubMed ID: 21113131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion.
    Lee JY; Lee KT; Lee JK; Lee KH; Jang KT; Heo JS; Choi SH; Kim Y; Rhee JC
    Br J Cancer; 2011 Mar; 104(6):1027-37. PubMed ID: 21364590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes.
    Keklikoglou I; Hosaka K; Bender C; Bott A; Koerner C; Mitra D; Will R; Woerner A; Muenstermann E; Wilhelm H; Cao Y; Wiemann S
    Oncogene; 2015 Sep; 34(37):4867-78. PubMed ID: 25500542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-140 regulates cell growth and invasion in pancreatic duct adenocarcinoma by targeting iASPP.
    Liang S; Gong X; Zhang G; Huang G; Lu Y; Li Y
    Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):174-81. PubMed ID: 26787707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis.
    Yuan P; He XH; Rong YF; Cao J; Li Y; Hu YP; Liu Y; Li D; Lou W; Liu MF
    Cancer Res; 2017 Jan; 77(1):100-111. PubMed ID: 27793842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease.
    Ramkaran P; Khan S; Phulukdaree A; Moodley D; Chuturgoon AA
    Cell Biochem Biophys; 2014 Mar; 68(2):259-66. PubMed ID: 23794009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.
    Bhaumik D; Scott GK; Schokrpur S; Patil CK; Campisi J; Benz CC
    Oncogene; 2008 Sep; 27(42):5643-7. PubMed ID: 18504431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
    Nakata K; Ohuchida K; Mizumoto K; Kayashima T; Ikenaga N; Sakai H; Lin C; Fujita H; Otsuka T; Aishima S; Nagai E; Oda Y; Tanaka M
    Surgery; 2011 Nov; 150(5):916-22. PubMed ID: 22018284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells.
    Xia J; Cheng L; Mei C; Ma J; Shi Y; Zeng F; Wang Z; Wang Z
    Curr Pharm Des; 2014; 20(33):5348-53. PubMed ID: 24479798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance.
    Meng Q; Liang C; Hua J; Zhang B; Liu J; Zhang Y; Wei M; Yu X; Xu J; Shi S
    Theranostics; 2020; 10(9):3967-3979. PubMed ID: 32226532
    [No Abstract]   [Full Text] [Related]  

  • 17. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
    Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
    J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway.
    Liu L; Liu FB; Huang M; Xie K; Xie QS; Liu CH; Shen MJ; Huang Q
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):580-586. PubMed ID: 30898507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways.
    Chen Y; Zeng Z; Shen X; Wu Z; Dong Y; Cheng JC
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
    Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
    Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.